β-amyloid controls altered Reelin expression and processing in Alzheimer's disease

Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the...

Full description

Bibliographic Details
Main Authors: Arancha Botella-López, Inmaculada Cuchillo-Ibáñez, Tiziana Cotrufo, Su San Mok, Qiao-Xin Li, María-Sagrario Barquero, Mara Dierssen, Eduardo Soriano, Javier Sáez-Valero
Format: Article
Language:English
Published: Elsevier 2010-03-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996109003489
_version_ 1831583054275018752
author Arancha Botella-López
Inmaculada Cuchillo-Ibáñez
Tiziana Cotrufo
Su San Mok
Qiao-Xin Li
María-Sagrario Barquero
Mara Dierssen
Eduardo Soriano
Javier Sáez-Valero
author_facet Arancha Botella-López
Inmaculada Cuchillo-Ibáñez
Tiziana Cotrufo
Su San Mok
Qiao-Xin Li
María-Sagrario Barquero
Mara Dierssen
Eduardo Soriano
Javier Sáez-Valero
author_sort Arancha Botella-López
collection DOAJ
description Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.
first_indexed 2024-12-17T20:35:27Z
format Article
id doaj.art-117caed6d1c54abf8badd8c518a80386
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-17T20:35:27Z
publishDate 2010-03-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-117caed6d1c54abf8badd8c518a803862022-12-21T21:33:28ZengElsevierNeurobiology of Disease1095-953X2010-03-01373682691β-amyloid controls altered Reelin expression and processing in Alzheimer's diseaseArancha Botella-López0Inmaculada Cuchillo-Ibáñez1Tiziana Cotrufo2Su San Mok3Qiao-Xin Li4María-Sagrario Barquero5Mara Dierssen6Eduardo Soriano7Javier Sáez-Valero8Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, E-03550, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), SpainInstituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, E-03550, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), SpainCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain; IRB-Barcelona, Parc Cientific de Barcelona, and Department of Cell Biology, University of Barcelona, E-08028, SpainDepartment of Pathology, The University of Melbourne, VIC 3010, Australia; The Mental Health Research Institute of Victoria, Parkville, VIC 3052, AustraliaDepartment of Pathology, The University of Melbourne, VIC 3010, Australia; The Mental Health Research Institute of Victoria, Parkville, VIC 3052, AustraliaDepartamento Neurología, Hospital Clínico San Carlos, Madrid, SpainGenes and Disease Program, Genomic Regulation Center (CRG), Pompeu Fabra University, Barcelona Biomedical Research Park (PRBB), and CIBER de Enfermedades Raras (CIBERER), Barcelona, E-08003, SpainCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain; IRB-Barcelona, Parc Cientific de Barcelona, and Department of Cell Biology, University of Barcelona, E-08028, SpainInstituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, E-03550, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain; Corresponding author. Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Av. Ramón y Cajal s/n, E-03550 Sant Joan d'Alacant, Spain. Fax: +34 965919561.Reelin is a glycoprotein that modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation. We recently reported altered cerebral Reelin expression in Alzheimer's disease (AD). Here we demonstrate pronounced Reelin changes at protein and mRNA levels in the frontal cortex in adult Down's syndrome (DS), where the extra copy of chromosome 21 leads to overexpression of β-amyloid. In cortical extracts of fetal DS samples we detected increased levels of the full-length Reelin and the 310-kDa fragment. Overexpression of mutant human amyloid precursor protein also led to an increase in levels of Reelin fragments in Tg2576 transgenic mice for human β-amyloid. Finally, in vitro Aβ42 treatment of SH-SY5Y neuroblastoma cells led to increased Reelin levels. An altered pattern of Reelin glycosylation was detected in extracts from the frontal cortex of AD patients and in Aβ42-treated SH-SY5Y cells, supporting the notion that β-amyloid triggers altered Reelin processing. These results provide evidence that Reelin expression and processing is altered in several amyloid conditions.http://www.sciencedirect.com/science/article/pii/S0969996109003489Alzheimer's diseaseDown's syndromeAmyloidReelinGlycoproteinCerebral cortex
spellingShingle Arancha Botella-López
Inmaculada Cuchillo-Ibáñez
Tiziana Cotrufo
Su San Mok
Qiao-Xin Li
María-Sagrario Barquero
Mara Dierssen
Eduardo Soriano
Javier Sáez-Valero
β-amyloid controls altered Reelin expression and processing in Alzheimer's disease
Neurobiology of Disease
Alzheimer's disease
Down's syndrome
Amyloid
Reelin
Glycoprotein
Cerebral cortex
title β-amyloid controls altered Reelin expression and processing in Alzheimer's disease
title_full β-amyloid controls altered Reelin expression and processing in Alzheimer's disease
title_fullStr β-amyloid controls altered Reelin expression and processing in Alzheimer's disease
title_full_unstemmed β-amyloid controls altered Reelin expression and processing in Alzheimer's disease
title_short β-amyloid controls altered Reelin expression and processing in Alzheimer's disease
title_sort β amyloid controls altered reelin expression and processing in alzheimer s disease
topic Alzheimer's disease
Down's syndrome
Amyloid
Reelin
Glycoprotein
Cerebral cortex
url http://www.sciencedirect.com/science/article/pii/S0969996109003489
work_keys_str_mv AT aranchabotellalopez bamyloidcontrolsalteredreelinexpressionandprocessinginalzheimersdisease
AT inmaculadacuchilloibanez bamyloidcontrolsalteredreelinexpressionandprocessinginalzheimersdisease
AT tizianacotrufo bamyloidcontrolsalteredreelinexpressionandprocessinginalzheimersdisease
AT susanmok bamyloidcontrolsalteredreelinexpressionandprocessinginalzheimersdisease
AT qiaoxinli bamyloidcontrolsalteredreelinexpressionandprocessinginalzheimersdisease
AT mariasagrariobarquero bamyloidcontrolsalteredreelinexpressionandprocessinginalzheimersdisease
AT maradierssen bamyloidcontrolsalteredreelinexpressionandprocessinginalzheimersdisease
AT eduardosoriano bamyloidcontrolsalteredreelinexpressionandprocessinginalzheimersdisease
AT javiersaezvalero bamyloidcontrolsalteredreelinexpressionandprocessinginalzheimersdisease